Cargando…
Glucosamine exposure reduces proteoglycan synthesis in primary human endothelial cells in vitro
PURPOSE: Glucosamine (GlcN) supplements are promoted for medical reasons, for example, for patients with arthritis and other joint-related diseases. Oral intake of GlcN is followed by uptake in the intestine, transport in the circulation and thereafter delivery to chondrocytes. Here, it is postulate...
Autores principales: | Reine, Trine M., Jenssen, Trond Geir, Kolset, Svein Olav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Co-Action Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035772/ https://www.ncbi.nlm.nih.gov/pubmed/27667774 http://dx.doi.org/10.3402/fnr.v60.32615 |
Ejemplares similares
-
Serglycin in Quiescent and Proliferating Primary Endothelial Cells
por: Reine, Trine M., et al.
Publicado: (2015) -
Editorial: Growth and Tissue Regeneration with focus on Proteoglycans
por: Pedersen, Mona Elisabeth, et al.
Publicado: (2023) -
Serglycin is part of the secretory repertoire of LPS-activated monocytes
por: Kolseth, Ingrid Benedicte M, et al.
Publicado: (2015) -
Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis
por: Deyab, Gia, et al.
Publicado: (2021) -
Glucosamine reduces the inhibition of proteoglycan metabolism caused by local anaesthetic solution in human articular cartilage: an in vitro study
por: Gulihar, Abhinav, et al.
Publicado: (2017)